These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 19252861)

  • 1. Therapeutic antibodies: current state and future trends--is a paradigm change coming soon?
    Dimitrov DS; Marks JD
    Methods Mol Biol; 2009; 525():1-27, xiii. PubMed ID: 19252861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic proteins.
    Dimitrov DS
    Methods Mol Biol; 2012; 899():1-26. PubMed ID: 22735943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic antibodies against cancer.
    Adler MJ; Dimitrov DS
    Hematol Oncol Clin North Am; 2012 Jun; 26(3):447-81, vii. PubMed ID: 22520975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody "gold rush".
    Maggon K
    Curr Med Chem; 2007; 14(18):1978-87. PubMed ID: 17691940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of antibody therapy.
    Elbakri A; Nelson PN; Abu Odeh RO
    Hum Immunol; 2010 Dec; 71(12):1243-50. PubMed ID: 20849901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage display-derived human antibodies in clinical development and therapy.
    Frenzel A; Schirrmann T; Hust M
    MAbs; 2016 Oct; 8(7):1177-1194. PubMed ID: 27416017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.
    Beck A; Wurch T; Reichert JM
    MAbs; 2011; 3(2):111-32. PubMed ID: 21441785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research and development of next generation of antibody-based therapeutics.
    Li J; Zhu Z
    Acta Pharmacol Sin; 2010 Sep; 31(9):1198-207. PubMed ID: 20694021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Belimumab: anti-BLyS human monoclonal antibody, anti-BLyS monoclonal antibody, BmAb, human monoclonal antibody to B-lymphocyte stimulator.
    Drugs R D; 2008; 9(3):197-202. PubMed ID: 18457473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development trends for human monoclonal antibody therapeutics.
    Nelson AL; Dhimolea E; Reichert JM
    Nat Rev Drug Discov; 2010 Oct; 9(10):767-74. PubMed ID: 20811384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
    Alfaleh MA; Alsaab HO; Mahmoud AB; Alkayyal AA; Jones ML; Mahler SM; Hashem AM
    Front Immunol; 2020; 11():1986. PubMed ID: 32983137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab: anti-IgE monoclonal antibody E25, E25, humanised anti-IgE MAb, IGE 025, monoclonal antibody E25, Olizumab, Xolair, rhuMAb-E25.
    BioDrugs; 2002; 16(5):380-6. PubMed ID: 12408744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering antibodies for clinical applications in cancer.
    Chester K; Pedley B; Tolner B; Violet J; Mayer A; Sharma S; Boxer G; Green A; Nagl S; Begent R
    Tumour Biol; 2004; 25(1-2):91-8. PubMed ID: 15192316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic monoclonal antibodies: a little history, a lot of engineering, and... some clinical successes].
    Siberil S; Dutertre CA; Boix C; Teillaud JL
    Transfus Clin Biol; 2005 Jun; 12(2):114-22. PubMed ID: 15907389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.